Welcome to our dedicated page for Home Fed Bancorp La SEC filings (Ticker: HFBL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trying to gauge how Home Federal Bancorp, Inc. of Louisiana finances construction projects or when its directors buy shares? This SEC Filings hub starts where EDGAR ends, guiding you from question to clarity in one click.
Search phrases like “Home Federal Bancorp insider trading Form 4 transactions” or “Home Federal Bancorp quarterly earnings report 10-Q filing” lead here because every document—10-K, 10-Q, 8-K, DEF 14A, and Form 4—updates in real time. Stock Titan’s AI instantly highlights net interest margin shifts, loan-to-deposit ratios, and branch-level credit trends, turning 200-page reports into plain-English briefs.
Not sure where to look? Follow this path:
- Open the latest 10-K for a line-by-line breakdown of residential, commercial, and multi-family loan exposure—our AI tags the sections investors usually miss.
- Use the 10-Q filter to compare quarter-over-quarter provision expense; the platform answers the common query, “Home Federal Bancorp earnings report filing analysis”.
- Set Form 4 alerts for Home Federal Bancorp Form 4 insider transactions real-time and spot executive trades before the market reacts.
- Review the proxy statement for Home Federal Bancorp proxy statement executive compensation without scrolling through footnotes.
- View Home Federal Bancorp 8-K material events explained to see how loan modifications or dividend changes unfold.
Because understanding community-bank risk demands more than raw PDFs, our AI-powered summaries make Home Federal Bancorp SEC filings explained simply. Save hours dissecting allowance calculations, track Home Federal Bancorp executive stock transactions Form 4, and act on insights, not guesswork.
Form 144 filed for Home Federal Bancorp, Inc. (HFBL) reporting a proposed sale of 8,200 shares of common stock through Raymond James with an aggregate market value of $110,700. The filing lists total outstanding shares as 3,084,764 and an approximate sale date of 09/17/2025. The shares to be sold were acquired in a series of stock awards between 2016 and 2024, most recently 3,000 shares awarded on 05/31/2024. The filer states no securities were sold in the past three months and includes the required attestation about material nonpublic information.